Steris STE
NYSE STE
$235.76 -1.15 (-0.49%)
As of: Aug 20, 2026 · 3:54 PM EDT

Steris (STE) Land & Improvements (2025 - 2026)

Steris (STE) posted quarterly Land & Improvements of $112.3 million for Q1 2026, up 5.84% year-over-year from $106.1 million in Q1 2025, and up 5.84% quarter-over-quarter from $106.1 million in Q1 2025.

Steris (STE) Land & Improvements (2025 - 2026) Analysis & Trends

Steris' Land & Improvements history runs 2 years deep, the most recent figure standing at $112.3 million for Q1 2026.

  • In Q1 2026, Land & Improvements rose 5.84% year-over-year to $112.3 million; the TTM figure through Mar 2026 stood at $112.3 million (up 5.84% YoY), while the FY2026 annual figure was $112.3 million, up 5.84% from the prior year.
  • Land & Improvements for Q1 2026 stood at $112.3 million, up from $106.1 million in the prior quarter.
  • The five-year high for Land & Improvements was $112.3 million in Q1 2026, with the low at $106.1 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn -
2 Stryker 126.18 Bn 122.71 Bn 4.50 Bn 1.81 Bn
3 Medtronic 118.63 Bn 109.41 Bn 6.41 Bn -
4 Boston Scientific 72.75 Bn 72.21 Bn 3.85 Bn 183.00 Mn
5 Edwards Lifesciences 52.10 Bn 47.85 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.68 Bn 31.57 Bn 2.18 Bn -
8 Koninklijke Philips 26.32 Bn 23.00 Bn 4.55 Bn -
9 Steris 23.10 Bn 22.62 Bn 684.20 Mn 112.50 Mn
10 Zimmer Biomet Holdings 19.10 Bn 18.69 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 112.50 Mn
Mar 31, 2026 112.30 Mn
Mar 31, 2025 106.10 Mn